Abstract
Aim:
To investigate the effect of peroxisome proliferator-activated receptor gamma (PPARγ) activation on the growth of rat hepatic stellate cells (HSC) and transforming growth factor beta (TGF-β)-induced connective tissue growth factor (CTGF) expression.
Methods:
After being treated with various amounts of the PPARγ natural ligand 15-deoxy-Δ12,14-prostaglandin J2 (15-d-PGJ2) or synthetic ligand GW7845, the status of HSC proliferation and apoptosis were detected by MTT assay and flow cytometry. Furthermore, HSC were treated with PPARγ-specific antagonist GW9662 prior to the addition of 15-d-PGJ2 or GW7845 and were subsequently stimulated with TGF-β1. The mRNA and protein levels of CTGF expression were detected by semi-quantitative RT-PCR and Western blotting analysis. Morphological changes in the HSC were observed by electron microscopy.
Results:
15-d-PGJ2 and GW7845 markedly inhibited HSC proliferation and induced cell apoptosis in a dose-dependent manner. Furthermore, PPARγ ligands significantly suppressed TGF-β1-induced CTGF expression (at both transcriptional and post-transcriptional levels) in HSC, and the inhibitory effect was dramatically, if not completely, abolished by pretreatment with GW9662, suggesting that the inhibition was indeed mediated by PPARγ. Moreover, morphological observation revealed that PPARγ activation caused obvious changes of HSC from activated to quiescent phenotype.
Conclusion:
The PPARγ ligand has a potent inhibitory effect on the growth of HSC and TGF-β1-induced CTGF expression, which makes it a potential antifibrotic candidate for the treatment and prevention of hepatic fibrosis.
Similar content being viewed by others
Article PDF
References
She H, Xiong S, Hazra S, Tsukamoto H . Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 2005; 280: 4959–67.
Lee SH, Seo GS, Park YN, Sohn DH . Nephroblastoma over-expressed gene (NOV) expression in rat hepatic stellate cells. Biochem Pharmacol 2004; 68: 1391–400.
Mann DA, Smart DE . Transcriptional regulation of hepatic stellate cell activation. Gut 2002; 50: 891–6.
Friedman SL . Liver fibrosis: from bench to bedside. J Hepatol 2003; 38: 38–53.
Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T . Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36: 200–9.
Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005; 37: 138–45.
Kobayashi H, Hayashi N, Hayashi K, Yamataka A, Lane GJ, Miyano T . Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int 2005; 21: 12–6.
Gao R, Ball DK, Perbal B, Brigstock DR . Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 2004; 40: 431–8.
Uchio K, Graham M, Dean NM, Rosenbaum J, Desmouliere A . Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen 2004; 12: 60–6.
Perbal B . CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62–4.
Xu J, Fu Y, Chen A . Activation of peroxisome proliferators-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003; 285: 20–30.
Sung CK, She H, Xiong S, Tsukamoto H . Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2004; 286: 722–9.
Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004; 279: 11392–401.
Planaguma A, Claria J, Miquel R, Lopez-Parra M, Titos E, Masferrer JL, et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPAR gamma activation. FASEB J 2005; 19: 1120–2.
Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274: 5830–4.
Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003; 83: 163–73.
Giannini S, Serio M, Galli A . Pleiotropic effects of thiazolidine-diones: taking a look beyond antidiabetic activity. J Endocrinol Invest 2004; 27: 982–91.
Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, et al. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther 2003; 306: 846–54.
Wang MY, Unger RH . Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. Am J Physiol Endocrinol Metab 2005; 288: 216–21.
Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, et al. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Acta Pharmacol Sin 2005; 26: 753–61.
Heaney AP, Fernando M, Melmed S . PPAR-gamma receptor ligands: novel therapy for pituitary adenomas. J Clin Invest 2003; 111: 1381–8.
Fauconnet S, Lascombe I, Chabannes E, Adessi GL, Desvergne B, Wahli W, et al. Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells. J Biol Chem 2002; 277: 23534–43.
Rachfal AW, Brigstock DR . Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003; 26: 1–9.
Gao R, Brigstock DR . Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 2004; 279: 8848–55.
Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H . An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 2003; 139: 1085–94.
Gao R, Brigstock DR . Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003; 27: 214–20.
Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101–8.
Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, et al. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res 2004; 95: 45–55.
Ozaki S, Sato Y, Yasoshima M, Harada K, Nakanuma Y . Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int 2005; 25: 817–28.
Hsu YC, Lin YL, Chiu YT, Shiao MS, Lee CY, Huang YT . Antifibrotic effects of Salvia miltiorrhiza on dimethylnitro-samine-intoxicated rats. J Biomed Sci 2005; 12: 185–95.
Han YP, Zhou L, Wang J, Xiong S, Garner WL, French SW, et al. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J Biol Chem 2004; 279: 4820–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Excellent Young Teachers Program of Ministry of Education, China (No 200065).
Rights and permissions
About this article
Cite this article
Sun, K., Wang, Q. & Huang, Xh. PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression. Acta Pharmacol Sin 27, 715–723 (2006). https://doi.org/10.1111/j.1745-7254.2006.00299.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00299.x
Keywords
This article is cited by
-
CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis
Journal of Cell Communication and Signaling (2021)
-
Angiotensin II induces connective tissue growth factor expression in human hepatic stellate cells by a transforming growth factor β-independent mechanism
Scientific Reports (2017)
-
Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings
Clinical and Experimental Medicine (2017)
-
Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
Cellular and Molecular Life Sciences (2013)
-
MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma
Acta Pharmacologica Sinica (2011)